iCAD Inc. announced that its PowerLook Tomo Detection has been named 2017 Product of the Year by the New Hampshire High Technology Council, a member-driven organization with a focus on advancing innovation throughout the State of New Hampshire. Built on deep learning technology, PowerLook Tomo Detection is the first and only concurrent-read cancer detection solution for digital breast tomosynthesis (DBT), according to the company, engineered to make it possible for radiologists to detect breast cancer more efficiently.

The Michael J. Fox Foundation for Parkinson's Research (MJFF) and the Tau Consortium announced a funding partnership to accelerate development of novel positron emission tomography (PET) imaging tracers for the detection of the alpha-synuclein and tau proteins in the living brain.

A study that integrated robust smoking cessation programs into an organized low-dose computed tomography (LDCT) lung cancer screening program found that the inclusion of both interventions has the potential to decrease mortality rates while being relatively cost-effective. William Evans, M.D., of McMaster University in Canada presented these findings at the International Association for the Study of Lung Cancer (IASLC) 18th World Conference on Lung Cancer (WCLC), Oct. 15-18 in Yokohama, Japan.

medQ Inc., provider of enterprise imaging workflow solutions, announced their collaboration with Advanced Medical Imaging of Lincoln, Neb., to customize the front end of AMI’s Q/ris 3000 electronic health record (EHR) to accommodate the need to automate and manage their Mammo Club operations.

A research team led by Eva Dyer, a computational neuroscientist and electrical engineer, has successfully imaged brains at a map-like or “meso” scale using the most powerful X-ray beams in the country. The imaging scale gives an overview of the intercellular landscape of the brain at a level relevant to small neural networks, which are at the core of the brain’s computational abilities.

The Netherlands Cancer Institute (NKI) announced it has received funding from the Dutch Cancer Society (KWF Kankerbestrijding) to test whether a novel molecular imaging technology can guide prostate cancer surgery. The project will evaluate the imaging technology’s ability to detect prostate cancer during surgery, with the aim of performing more accurate removal of cancerous tissue.

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published appropriate use criteria (AUC) for FDG PET/CT (positron emission tomography/computed tomography) in restaging and treatment response assessment of malignant disease. As cancer patients move through therapy, FDG PET/CT has proven an effective tool for assessing treatment response and updating the stage of malignancy. This AUC aims to improve utilization and guide providers across specialties in its use.

October 25, 2017 — ViewRay Inc. announced outcomes data presented during the recent 2017 Annual Meeting of the American ...

Philips recently announced the key findings of its research focused on the patient experience in diagnostic imaging procedures. Philips’ Patient Experience in Imaging Study surveyed 603 patients in the United States and Germany about their satisfaction, expectations, preferences and unmet needs with diagnostic imaging procedures in the past year. Patients identified trust in the referring doctor, communication, comfort, safety and getting the image right the first time as key priorities. The research provides insight into how patients perceive imaging procedures, what they value during the process, and what healthcare professionals can do to create a more patient-centered imaging experience.